Cytosorbents (CTSO) Treasury Shares (2016 - 2026)

Cytosorbents has reported Treasury Shares for 11 years, with the latest figure at $2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares fell 5.45% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 5.45% YoY), and the FY2025 full-year result was $775301.0, down 72.4% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.6 million, up from $775301.0 in the prior quarter.
• The five-year high for Treasury Shares was $2.8 million in Q3 2025, with the low at $125340.0 in Q2 2022.
• Historically, Treasury Shares has averaged $1.3 million across 5 years, with a median of $641336.0 in 2024.
• Annual changes were most pronounced in 2023 — Treasury Shares surged 804.7% — and 2025, when it sank 72.4%.
• Cytosorbents' Treasury Shares stood at $312092.0 in 2022, then surged by 804.7% to $2.8 million in 2023, then fell by 0.5% to $2.8 million in 2024, then slumped by 72.4% to $775301.0 in 2025, then jumped by 239.93% to $2.6 million in 2026.
• The last three Treasury Shares figures came in at $2.6 million (Q1 2026), $775301.0 (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.